Trials / Unknown
UnknownNCT04309071
Saliva Insulin Responses to a Standardized Meal Tolerance Test in Humans
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
Recent evidence suggests that hyperinsulinemia (i.e., elevated insulin levels) is the primary causative factor in obesity. Insulin promotes fat storage and prevents fat breakdown, suggesting that weight loss would be optimized if insulin levels are managed and kept low. Understanding how different foods impact insulin levels could therefore aid in personalized weight loss (or weight maintenance) advice. It has been shown that salivary insulin can track plasma insulin following different meals and can delineate between lean and obese people. Thus, it was suggested that salivary insulin could be a potential surrogate for plasma insulin. The purpose of this study is to measure fasting saliva insulin, and salivary insulin responses to a standardized meal tolerance test in individuals with different body mass index (BMI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dietary intervention | Salivary insulin responses to a standardized mixed meal |
Timeline
- Start date
- 2019-01-04
- Primary completion
- 2022-06-01
- Completion
- 2022-09-01
- First posted
- 2020-03-16
- Last updated
- 2021-09-28
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04309071. Inclusion in this directory is not an endorsement.